Epiflux

2024-515540-23-00 Therapeutic exploratory (Phase II) Ongoing, recruiting

Start 15 Apr 2020 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites

Overview

Sponsor-declared trial summary

Phase Therapeutic exploratory (Phase II)
Status Ongoing, recruiting
Participants planned 60
Countries 1
Sites 1

Focal epilepsy

Key facts

Sponsor
Medical University Of Vienna
Participant type
Patients, Healthy volunteers
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Nervous System Diseases [C10]
Trial duration
15 Apr 2020 → ongoing
Decision date (initial)
2024-10-14
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2024-515540-23-00
EudraCT number
2019-003137-42

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Focal epilepsy

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Medical University Of Vienna

Sponsor organisation
Medical University Of Vienna
Address
Spitalgasse 23, Alsergrund Alsergrund
City
Vienna
Postcode
1090
Country
Austria

Scientific contact point

Organisation
Medical University Of Vienna
Contact name
Department of Clinical Pharmacology

Public contact point

Organisation
Medical University Of Vienna
Contact name
Department of Clinical Pharmacology

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Austria Ongoing, recruiting 60 1
Rest of world 0

Investigational sites

Austria

1 site · Ongoing, recruiting
Medical University Of Vienna
Department of Clinical Pharmacology, Waehringer Guertel 18-20, Alsergrund, Vienna

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Austria 2020-04-15 2021-03-30

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-08-29 Austria Acceptable
2024-10-09
2024-10-14